Bora Pharmaceuticals Co., Ltd.
Bora Pharmaceuticals Co., Ltd. (TAI: 6472) is trading at NT$429.50, about ₹1,292 at today's TWD/INR rate, as of 1 Oct 2026, 1:21 AM ET, up 1.30% today. Bora Pharmaceuticals is not currently available to trade on Paasa; this page shows its price, statistics and the Indian tax treatment for information.
Quote
Today's low
NT$426.50
Today's high
NT$445.50
52 week low
NT$330.50
52 week high
NT$703.00
6472 opened at NT$436.00, closed previously at NT$424.00, and has traded between NT$330.50 and NT$703.00 over the past 52 weeks.
About
Globally, Bora Pharmaceuticals Co., LTD. is engaged in the comprehensive lifecycle of pharmaceutical products, encompassing research and development, manufacturing, distribution, and sales. The organization operates through key divisions, including Sales, Contract Development & Manufacturing Organization (CDMO), and other ancillary services. Bora produces and markets a diverse range of medicines, from generic and proprietary brand-name drugs to over-the-counter (OTC) remedies. Beyond its in-house portfolio, the company provides extensive contract development and manufacturing solutions. These CDMO services cover all stages of pharmaceutical development, clinical and commercial production, specialized packaging and serialization, rigorous analytical and microbiological quality control, and expert guidance on regulatory compliance. Furthermore, Bora's offerings extend to nutritional supplements, skincare products, and various biotechnical services. The company distributes its goods directly to healthcare facilities such as clinics, pharmacies, and pharmacy chains, as well as to drugstores. It also leverages distributors to supply larger institutions like medical centers, corporate and public hospitals, and regional and district hospitals. Established in 2007, Bora Pharmaceuticals Co., LTD. is based in Taipei City, Taiwan.
Key statistics
Avg. volume
1.25M
Market cap
NT$54.71B
P/E Ratio
35.03
Price-to-sales ratio
2.80
Enterprise value
NT$73.99B
Free cash flow yield
5.44%
Debt-to-equity ratio
1.44
Return on equity
19.38%
ROIC
7.48%
Beta
0.46
Dividend yield
2.33%
Last dividend
NT$10.00
Financial overview
Revenue
NT$19.01B
Earnings per share
NT$23.90
Free cash flow
NT$3.31B
Net profit margin
7.91%
Gross margin
39.06%
EBITDA
NT$4.23B
Revenue growth
-1.21%
Similar securities
This is not an investment recommendation
Bora Pharmaceuticals for Indian investors
Bora Pharmaceuticals is listed on the Taiwan Stock Exchange. It is not currently available to trade on Paasa; the figures on this page are for information, and the tax notes below apply to Indian residents who hold it.
Taxes on Bora Pharmaceuticals for Indian residents
Trading and limits
- Trading hours
- 9:00 am – 1:30 pm SGT
- LRS limit
- $250,000Per financial year, under the RBI's Liberalised Remittance Scheme.
Tax for Indian residents
- TCS on remittance
- 20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
- Capital gains in India
- 12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
- Dividends
- Slab rateDividends are taxed at your slab rate in India. Bora Pharmaceuticals’ current yield is 2.33%.Dividend tax explained
FAQs
Can I buy Bora Pharmaceuticals on Paasa?
Bora Pharmaceuticals (6472) has been listed on the Taiwan Stock Exchange since 2023, in the Drug Manufacturers - Specialty & Generic industry. Bora Pharmaceuticals is not currently available to trade on Paasa; the figures on this page are for information. Indian residents who hold it through another broker still declare it under the rules below.
How much does one Bora Pharmaceuticals share cost in rupees?
One Bora Pharmaceuticals share is NT$429.50 — about ₹1,292 at a TWD/INR rate of 3.01 on 30 Sep 2026. Both the Bora Pharmaceuticals price and the rupee rate move during the day, so the rupee cost changes with them.
What are the LRS and TCS rules for investing abroad from India?
Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability.
How are gains on Bora Pharmaceuticals shares taxed in India?
Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the TWD/INR rate on the purchase and the sale date, so the rupee move counts alongside the Bora Pharmaceuticals price.
Does Bora Pharmaceuticals pay a dividend, and how is it taxed in India?
Yes. Bora Pharmaceuticals pays a dividend and the current yield is 2.33%; the last declared dividend was NT$10.00 per share, about ₹30.08. Dividends are taxed at your slab rate in India.
When does TAI trade, in Indian time?
The Taiwan Stock Exchange trades 6:30 am – 11:00 am IST in Indian time.
Do I have to declare Bora Pharmaceuticals shares in my Indian tax return?
Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. The holding is reported with its cost and its closing value.
Does the rupee rate affect what I make on Bora Pharmaceuticals?
Yes. Bora Pharmaceuticals is priced in TWD, so your rupee outcome combines the TWD move with the TWD/INR move between the day you remit and the day you convert back.